Central serous chorioretinopathy after local application of glucocorticoids for skin disorders.
Karadimas
Panagiotis
P
Medical Retina Unit, First Department of Ophthalmology, Henry Dunant Hospital, 107 Mesogion Avenue, 11526 Athens, Greece. t_karadimas@yahoo.com
Kapetanios
Anastasios
A
Bouzas
Evrydiki A
EA
D000287:Administration, Topical; D000328:Adult; D015862:Choroid Diseases / Q000139:chemically induced* / Q000175:diagnosis; D012628:Dermatitis, Seborrheic / Q000188:drug therapy*; D004060:Diflucortolone / Q000008:administration & dosage / Q000009:adverse effects* / Q000031:analogs & derivatives*; D005451:Fluorescein Angiography; D005938:Glucocorticoids / Q000008:administration & dosage / Q000009:adverse effects*; D006801:Humans; D006854:Hydrocortisone / Q000008:administration & dosage / Q000009:adverse effects* / Q000031:analogs & derivatives*; D008297:Male; D012164:Retinal Diseases / Q000139:chemically induced* / Q000175:diagnosis; D014010:Tinea Versicolor / Q000188:drug therapy*; D014792:Visual Acuity
D005938:Glucocorticoids; C013486:diflucortolone valerate; C021650:hydrocortisone acetate; D004060:Diflucortolone; D006854:Hydrocortisone